Moreover, we found that the inhibition of SOAT1 in human podocytes reduced lipotoxicity-mediated podocyte injury in DKD in association with increased ABCA1 expression and ABCA1-mediated cholesterol efflux [54]. Here, ABCA1 is linked to diabetic kidney disease.